Ocular Surface Metabolo-lipidomics in Lateral Amyotrophic Sclerosis
NCT04953286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2025-12-22
Summary
Amyotrophic Lateral Sclerosis (ALS) is the most common neurodegenerative disease affecting the motor neuron. Currently, there is no diagnostic test and no examination that can predict the evolution of this pathology. The search for diagnostic and prognostic biomarkers is therefore essential for a better understanding of the pathophysiology of ALS, which remains poorly understood, and also for better clinical management. The ocular surface, made up of liquid elements, tears, and cells, is an accessible anatomical-physiological entity that has demonstrated its usefulness in the identification of biomarkers in neurodegenerative diseases such as Parkinson's or Alzheimer's. To date, no study has explored the ocular surface as a biomarker in ALS
Conditions
Interventions
- OTHER
-
Evaluation of the corneal innervation
Contact corneal confocal microscopy
- OTHER
-
Slit lamp examination and undilated fundus
Slit lamp examination and undilated fundus
- OTHER
-
Conjunctival impression
Conjunctival impression with anesthetic instillation
- OTHER
-
Samples of basal tears
Collection of basal tears without instillation of anesthetic with a Schirmer strip for 5 minutes and by microcapillary
- OTHER
-
Central corneal sensitivity
Central corneal sensitivity using a Cochet-Bonnet esthesiometer (Luneau©)
- OTHER
-
Measure of visual acuity
ETDRS and Parinaud scale
- OTHER
-
Interferometry
Non-contact exam measuring N.I.B.U.T (Non-invasive break-up time), quantitative and qualitative evaluation of the meibomian glands and quantitative evaluation of the tear meniscus
Sponsors & Collaborators
-
University Hospital, Tours
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-09-17
- Primary Completion
- 2023-09-30
- Completion
- 2023-09-30
Countries
- France
Study Locations
More Related Trials
-
Characterization of Potential Biomarkers of Eye Disease and Vision
NCT02500862 ·Status: ACTIVE_NOT_RECRUITING
-
Neuroretinal Biomarkers in Neurodegenerative Diseases
NCT02047760 ·Status: COMPLETED
-
Comparison of Cytokine Profiles in Aqueous Humor of Patients With Age Related Macular Degeneration (AMD)
NCT03418220 ·Status: COMPLETED ·Phase: NA
-
Identification and Treatment of Feeder Vessels in Macular Degeneration
NCT00018070 ·Status: COMPLETED ·Phase: PHASE1
-
Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser
NCT04234438 ·Status: COMPLETED ·Phase: NA
-
Choroidal Thickness in Optic Neuropathy
NCT02382627 ·Status: TERMINATED
-
Bimodal and Coaxial High Resolution Ophtalmic Imaging
NCT04620876 ·Status: UNKNOWN ·Phase: NA
-
The Relationship Between Macular OCTA and GCIPL and Their Combinational Index Using AI
NCT03369886 ·Status: UNKNOWN ·Phase: NA
-
Pupillometry Dynamic Measures in Patients Without Ocular or Neurological Disease
NCT02894281 ·Status: COMPLETED
-
Fundus Autofluorescence Imaging in Age-related Macular Degeneration Using Confocal Scanning Laser Ophthalmoscopy
NCT00393692 ·Status: COMPLETED
-
Prediction of Progression of Retinal Ischemia in Diabetes
NCT05581225 ·Status: ACTIVE_NOT_RECRUITING
-
Determination of Physical Parameters Relevant to Ophthalmic Lasers
NCT02023073 ·Status: RECRUITING
-
Retinal and Cognitive Dysfunction in Type 2 Diabetes
NCT04281186 ·Status: COMPLETED
-
Evaluating the Safety of the SPECTRALIS CENTAURUS Device
NCT04968756 ·Status: RECRUITING ·Phase: NA
-
Early Diagnosis in Glaucoma With GDxVcc
NCT01022281 ·Status: COMPLETED
-
A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease
NCT07254234 ·Status: NOT_YET_RECRUITING
-
Treatment Trial for Acute Central Serous Chorioretinopathy
NCT02784665 ·Status: COMPLETED ·Phase: NA
-
Relationship Between Alzheimer Disease and Diminution of the Three Macular Nervous Retinal Layers
NCT04794634 ·Status: COMPLETED ·Phase: NA
-
Performance Evaluation of Pupillary Reactivity in Monitoring of Brain-damaged Patients in Intensive Care
NCT01796886 ·Status: UNKNOWN ·Phase: NA
-
Development of a Deep Learning System for Identification of Neuro-Ophthalmological Conditions on Color Fundus Photographs in Emergency Department
NCT06643338 ·Status: RECRUITING
-
Size Progression of Macular Degeneration After Cataract Surgery
NCT01165801 ·Status: COMPLETED ·Phase: PHASE4
-
MRI Versus Ocular UltraSonography for a Non Contact Evaluation of Ocular Layers
NCT05300698 ·Status: RECRUITING
-
Panmacular Versus Minimal Micropulse Laser Therapy in Central Serous Chorioretinopathy
NCT04410861 ·Status: UNKNOWN ·Phase: NA
-
New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography.
NCT05902884 ·Status: UNKNOWN ·Phase: NA
-
Central Serous Chorioretinopathy: Etiology, Course and Prognosis
NCT01378130 ·Status: COMPLETED